Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

This is the first prospective study of treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic malignancy derived from plasmacytoid dendritic cells that typically involves the skin and rapidly progresses to a leukemia phase. Despite being initially...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Frankel, Arthur E., Woo, Jung H., Ahn, Chul, Pemmaraju, Naveen, Medeiros, Bruno C., Carraway, Hetty E., Frankfurt, Olga, Forman, Stephen J., Yang, Xuezhong A., Konopleva, Marina, Garnache-Ottou, Francine, Angelot-Delettre, Fanny, Brooks, Christopher, Szarek, Michael, Rowinsky, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260361/
https://ncbi.nlm.nih.gov/pubmed/24859366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-04-566737
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados